Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 093
Main content starts here.
The exemplified claim, which does not recite an activity, could raise an issue as to how one skilled in the art would use a DNA sequence having 40 percent identity.